Treatment with doxorubicin-based protocol in cardiac involvement diffuse large B-cell lymphoma: A case report.

Atakan TekinalpTaha U KarsHatice Z DikiciPınar D YılmazSinan DemirciogluÖzcan Çeneli

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)

Because of the cardiotoxicity of doxorubicin-based protocols, patients should be evaluated according to cardiac functions before and during the chemotherapy.

Keyphrases

diffuse large b cell lymphoma
end stage renal disease
left ventricular
epstein barr virus
drug delivery
ejection fraction
newly diagnosed
chronic kidney disease
randomized controlled trial
prognostic factors
squamous cell carcinoma
patient reported outcomes
patient reported
chemotherapy induced